製品の概要

  • 製品名Anti-Ephrin A1 antibody
    Ephrin A1 一次抗体 製品一覧
  • 製品の詳細
    Rabbit polyclonal to Ephrin A1
  • アプリケーション適用あり: ELISA, ICC/IF, WBmore details
  • 種交差性
    交差種: Human
    交差が予測される動物種: Mouse, Rat
  • 免疫原

    Synthetic peptide derived from an internal sequence of human Ephrin A1.

  • ポジティブ・コントロール
    • HeLa cells, extracts from 293 cells and Jurkat cells.

製品の特性

アプリケーション

Our Abpromise guarantee covers the use of ab65072 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

アプリケーション Abreviews 特記事項
ELISA 1/10000.
ICC/IF 1/500 - 1/1000.
WB 1/500 - 1/1000. Detects a band of approximately 24 kDa (predicted molecular weight: 24 kDa).

ターゲット情報

  • 機能Plays an important role in angiogenesis and tumor neovascularization. The recruitement of VAV2, VAV3 and PI3-kinase p85 subunit by phosphorylated EPHA2 is critical for EFNA1-induced RAC1 GTPase activation and vascular endothelial cell migration and assembly (By similarity). Exerts anti-oncogenic effects in tumor cells through activation and down-regulation of EPHA2. Activates EPHA2 by inducing tyrosine phosphorylation which leads to its internalization and degradation. Acts as a negative regulator in the tumorigenesis of gliomas by down-regulating EPHA2 and FAK. Can evoke collapse of embryonic neuronal growth cones.
  • 組織特異性Brain. Down-regulated in primary glioma tissues compared to the normal tissues. The soluble monomeric form is expressed in the glioblastoma multiforme (GBM) and breast cancer cells (at protein level).
  • 配列類似性Belongs to the ephrin family.
  • 翻訳後修飾Undergo proteolysis by a metalloprotease to give rise to a soluble monomeric form.
  • 細胞内局在Secreted and Cell membrane.
  • Information by UniProt
  • 参照データベース
  • 別名
    • B61 antibody
    • ECKLG antibody
    • EFL 1 antibody
    • EFL1 antibody
    • EFNA 1 antibody
    • Efna1 antibody
    • EFNA1_HUMAN antibody
    • EPH related receptor tyrosine kinase ligand 1 antibody
    • EPH-related receptor tyrosine kinase ligand 1 antibody
    • Ephrin-A1 antibody
    • Ephrin-A1, secreted form antibody
    • EphrinA1 antibody
    • EPLG 1 antibody
    • EPLG1 antibody
    • Immediate early response protein B61 antibody
    • LERK 1 antibody
    • LERK-1 antibody
    • LERK1 antibody
    • Ligand of eph related kinase 1 antibody
    • OTTHUMP00000033242 antibody
    • OTTHUMP00000033271 antibody
    • secreted form antibody
    • TNF alpha-induced protein 4 antibody
    • TNFAIP 4 antibody
    • TNFAIP4 antibody
    • Tumor necrosis factor alpha induced protein 4 antibody
    • Tumor necrosis factor alpha-induced protein 4 antibody
    see all

Anti-Ephrin A1 antibody 画像

  • All lanes : Anti-Ephrin A1 antibody (ab65072) at 1/500 dilution

    Lane 1 : extracts from 293 cells
    Lane 2 : extracts from Jurkat cells
    Lane 3 : extracts from Jurkat cells with immunizing peptide at 5 µg

    Lysates/proteins at 5 µg per lane.


    Predicted band size : 24 kDa
    Observed band size : 24 kDa
    Additional bands at : >117 kDa. We are unsure as to the identity of these extra bands.
  • ab65072 at 1/500 dilution staining HeLa cells without (left) and with (right) immunizing peptide.
  • All lanes : Anti-Ephrin A1 antibody (ab65072) at 1 µg/ml

    Lane 1 : Recombinant Human Ephrin A1 protein (ab112282) at 0.1 µg
    Lane 2 : Recombinant Human Ephrin A1 protein (ab112282) at 0.01 µg

    Secondary
    Goat Anti-Rabbit IgG H&L (HRP) preadsorbed (ab97080) at 1/5000 dilution
    Developed using the ECL technique

    Performed under reducing conditions.

    Exposure time : 150 seconds

Anti-Ephrin A1 antibody (ab65072) 使用論文

ab65072 has not yet been referenced specifically in any publications.

Product Wall

Thank you for contacting Abcam.

The immunogen sequence for ab65072 has no significant homology with the sequence you provided below.

If there is anything else I can help you with, please let me know.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"